- Home
- BKSY vs CSTL Comparison
BKSY vs CSTL Comparison
Compare BKSY & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- CSTL
- Stock Information
- Founded
- BKSY 2013
- CSTL 2007
- Country
- BKSY United States
- CSTL United States
- Employees
- BKSY N/A
- CSTL N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- CSTL Medical Specialities
- Sector
- BKSY Technology
- CSTL Health Care
- Exchange
- BKSY Nasdaq
- CSTL Nasdaq
- Market Cap
- BKSY 643.3M
- CSTL 555.8M
- IPO Year
- BKSY N/A
- CSTL 2019
- Fundamental
- Price
- BKSY $18.15
- CSTL $20.09
- Analyst Decision
- BKSY Strong Buy
- CSTL Strong Buy
- Analyst Count
- BKSY 6
- CSTL 6
- Target Price
- BKSY $23.50
- CSTL $37.67
- AVG Volume (30 Days)
- BKSY 2.0M
- CSTL 682.4K
- Earning Date
- BKSY 08-07-2025
- CSTL 08-04-2025
- Dividend Yield
- BKSY N/A
- CSTL N/A
- EPS Growth
- BKSY N/A
- CSTL N/A
- EPS
- BKSY N/A
- CSTL N/A
- Revenue
- BKSY $104,662,000.00
- CSTL $346,269,000.00
- Revenue This Year
- BKSY $20.84
- CSTL N/A
- Revenue Next Year
- BKSY $31.78
- CSTL $1.62
- P/E Ratio
- BKSY N/A
- CSTL N/A
- Revenue Growth
- BKSY N/A
- CSTL 20.40
- 52 Week Low
- BKSY $3.86
- CSTL $14.59
- 52 Week High
- BKSY $28.85
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- BKSY 45.97
- CSTL 62.20
- Support Level
- BKSY $17.29
- CSTL $18.99
- Resistance Level
- BKSY $18.80
- CSTL $20.18
- Average True Range (ATR)
- BKSY 1.31
- CSTL 0.95
- MACD
- BKSY -0.25
- CSTL 0.37
- Stochastic Oscillator
- BKSY 39.94
- CSTL 81.57
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.